Chargement en cours...
Is RAGE still a therapeutic target for Alzheimer's disease?
The receptor for advanced glycation end products (RAGE) is a multiligand receptor involved in inflammatory disorders, tumor outgrowth, diabetic complications and Alzheimer's disease (AD). RAGE transports circulating amyloid-β toxins across the blood–brain barrier (BBB) into the brain. RAGE–amyl...
Enregistré dans:
| Publié dans: | Future Med Chem |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4973574/ https://ncbi.nlm.nih.gov/pubmed/22571615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc.12.51 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|